Margo K. Storey
About Margo K. Storey
Margo K. Storey is a Senior Manager at Cronos Group, where she leads a team focused on developing manufacturing processes for culturing rare cannabinoids. With a Ph.D. in Biochemistry from Dalhousie University, she has extensive experience in research and development, particularly in the field of cannabinoid manufacturing.
Current Role at Cronos Group
Margo K. Storey serves as a Senior Manager at Cronos Group since 2021. In this role, she leads a team dedicated to developing manufacturing processes for culturing rare cannabinoids. Her expertise in cannabinoid manufacturing processes has been instrumental in advancing the company’s research and development initiatives.
Previous Experience at Apotex Fermentation Inc
Margo K. Storey held several positions at Apotex Fermentation Inc. She worked as Acting Manager for R&D Fermentation and Microbiology for six months in 2015. Following this, she served as Manager for R&D Fermentation and Microbiology from 2016 to 2019, and as Program Manager for six months in 2019. Additionally, she worked as a Senior Research Scientist from 2008 to 2015, contributing to various research projects.
Postdoctoral Fellowship at National Jewish Medical and Research Center
From 1998 to 2002, Margo K. Storey was a Postdoctoral Fellow at the National Jewish Medical and Research Center. This four-year tenure allowed her to expand her research capabilities and gain valuable experience in the field of biochemistry.
Educational Background in Biochemistry
Margo K. Storey earned her Ph.D. in Biochemistry from Dalhousie University, where she studied from 1993 to 1997. Prior to that, she completed her BScH in Biochemistry at Queen's University from 1989 to 1993. Her educational background laid the foundation for her extensive career in research and development.
Research Experience at CanAm Bioresearch
Margo K. Storey worked as a Senior Research Scientist at CanAm Bioresearch from 2002 to 2008. During her six years there, she contributed to various research initiatives, further enhancing her expertise in biochemistry and cannabinoid research.